Drug Discovery Techniques Open the Door to RNA-targeted Drugs
Drug Discovery Techniques Open the Door to RNA-targeted Drugs
New ways to search for druggable RNAs and matching small molecules
Drug Discovery Techniques Open the Door to RNA-targeted Drugs
Drug Discovery Techniques Open the Door to RNA-targeted Drugs

New ways to search for druggable RNAs and matching small molecules

New ways to search for druggable RNAs and matching small molecules

drug development
MIT Researcher Allegedly Copied Other Groups’ Drug Designs
MIT Researcher Allegedly Copied Other Groups’ Drug Designs
Catherine Offord | May 29, 2019
Executives at a biotech that develops new antibodies argue that Ram Sasisekharan didn’t come up with the structures for at least two experimental therapies that his group has described.
Autism Symptoms May Improve with Modification of Hormone Pathway
Autism Symptoms May Improve with Modification of Hormone Pathway
Catherine Offord | May 2, 2019
Two clinical trials that altered vasopressin signaling report improved social functions in people with autism spectrum disorder, but researchers caution against overinterpreting the results.
Artificial Intelligence Shakes Up Drug Discovery
Artificial Intelligence Shakes Up Drug Discovery
Bianca Nogrady | May 1, 2019
The pharmaceutical industry is looking to machine learning to overcome complex challenges in drug development.
Q&A: Epigenetic Therapies for Breast Cancer
Q&A: Epigenetic Therapies for Breast Cancer
Katarina Zimmer | Apr 4, 2019
Breast cancer researcher and oncologist Nancy Davidson discusses what we’ve learned from the first wave of epigenetic trials for breast cancer, and what challenges lie ahead before such therapies reach the clinic.
Scientists Take Aim at Disease-Causing RNAs Using Small-Molecule Drugs
Scientists Take Aim at Disease-Causing RNAs Using Small-Molecule Drugs
Claire Asher | Apr 1, 2019
Renewed interest from the biotech industry sparks hope for drugging the nucleic acid to treat cancer and other conditions.
Miracle Elixirs
Miracle Elixirs
Bob Grant | Apr 1, 2019
A long way into the quest to vanquish cancer, our ears strain to hear the words, “Cancer is cured”—a yearning that can cloud our judgment.
FDA Commissioner Scott Gottlieb Announces Resignation
FDA Commissioner Scott Gottlieb Announces Resignation
Jef Akst | Mar 5, 2019
Gottlieb will step down after two years at the helm of the US Food and Drug Administration to spend more time with his family.
Drugs, Developed
Drugs, Developed
Bob Grant | Mar 1, 2019
In an era of instant communication, we must be careful how word of new and untested treatments is shared.
Are We Headed for a New Era of Malaria Drug Resistance?
Are We Headed for a New Era of Malaria Drug Resistance?
Natalie Slivinski | Mar 1, 2019
Plasmodium falciparum has shown an ability to evade everything we throw at it, most recently artemisinin-based combination therapies, today’s front-line treatment.